Photodynamic therapy for corneal neovascularization using polymeric micelles encapsulating dendrimer porphyrins

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 3, 2008, Pages 894-899

  Sugisaki, Kenji ^a   Usui, Tomohiko ^a   Nishiyama, Nobuhiro ^b   Jang, Woo Dong ^c,d   Yanagi, Yasuo ^a   Yamagami, Satoru ^a   Amano, Shiro ^a   Kataoka, Kazunori ^c,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMER; DENDRIMER ZINC PORPHYRIN; MACROGOL DERIVATIVE; POLYETHYLENEGLYCOL B POLY(LYSINE); PORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG; (O METHYLPOLY(ETHYLENE GLYCOL) O' SUCCINYL) N EPSILON POLY(L LYSINE); (O-METHYLPOLY(ETHYLENE GLYCOL)-O'-SUCCINYL)-N-EPSILON-POLY(L-LYSINE); DRUG CARRIER; FLUORESCEIN ISOTHIOCYANATE; HEMATOPORPHYRIN ZINC; METALLOPORPHYRIN; PHOTOSENSITIZING AGENT; POLYLYSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA LIMBUS; CORNEA NEOVASCULARIZATION; DIODE LASER; DRUG ACCUMULATION; DRUG EFFECT; DRUG EFFICACY; DRUG UPTAKE; ENCAPSULATION; FLUORESCENCE; MALE; MICELLE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; ANIMAL; C57BL MOUSE; DISEASE MODEL; PHOTOCHEMOTHERAPY;

ANIMALS; CORNEAL NEOVASCULARIZATION; DENDRIMERS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FLUORESCEIN-5-ISOTHIOCYANATE; MALE; METALLOPORPHYRINS; MICE; MICE, INBRED C57BL; MICELLES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYETHYLENE GLYCOLS; POLYLYSINE;

EID: 41949092444     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-0389     Document Type: Article

References (25)

1. Lee P, Wang CC, Adamis AP. Ocular neovascularization an epidemiologic review. Surv Ophthalmol. 1998;43:245-269.
2. Williams KA, Esterman AJ, Barlett C, Holland H, Hornsby NB, Coster DJ. How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantaion. 2006;81:896-901.
3. Epstein RJ, Stulting RD, Hendricks RL, Harris DM. Corneal neovascularization: pathogenesis and inhibition. Cornea. 1987;6:250-257.
4. Marsh RJ, Marshall J. Treatment of lipid keratopathy with the argon laser. Br J Ophthalmol. 1982;66:127-135.
5. Mendelsohn AD, Stock EL, Lo GG, et al. Laser photocoagulation of feeder vessels in lipid keratopathy. Ophthalmic Surg. 1986;17:502-508.
6. Nirankari VS, Baer JC. Corneal argon laser photocoagulation for neovascularization in penetrating keratoplasty. Ophthalmology. 1986;93:1304-1309.
7. Marsh RJ. Argon laser treatment of lipid keratopathy. Br J Ophthalmol. 1988;72:900-904.
8. Lai CM, Spilsbury K, Brankov M, Zaknich T, Rakoczy PE. Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA. Exp Eye Res. 2002;75:625-634.
9. Brooks BJ, Ambati BK, Marcus DM, Ratanasit A. Photodynamic therapy for corneal neovascularization and lipid degeneration. BrJ Ophthalmol. 2004;88:840.
10. Nishiyama N, Stapert RH, Zahng GD, et al. Light-harvesting ionic dendrimer porphyrins as new photosensitizers for photodynamic therapy. Bioconjug Chem. 2003;14:58-66.
11. Jang WD, Nishiyama N, Zhang GD, et al. Supramolecular nanocarrier of anionic dendrimer porphyrins with PEGylated cationic block copolymer to enhance intracellular photodynamic efficacy. Angew Chem Int Ed. 2005;44:419-423.
12. Ideta R, Tasaka F, Jang WD, et al. Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer. Nano Lett. 2005;5:2426-2431.
13. Usui T, Sugisaki K, Amano S, Jang WD, Nishiyama N, Kataoka K. New drug delivery for corneal neovascularization using polyion complex micelles. Cornea. 2005;24:S39-S42.
14. Awan MA, Rarin SA. Review of photodynamic therapy. Surgeon. 2006;4:231-236.
15. Harding S. Photodynamic therapy in the treatment of subfoveal choroidal neovascularization. Eye. 2001;15:407-412.
16. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP report no. 1. Ophthalmology. 2001;108:841-852.
17. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report: Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Arch Ophthalmol. 1999;117:1329-1345.
18. Gohto Y, Obana A, Kaneda K, Miki T. Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization. Exp Eye Res. 1998;67:213-322.
19. Holtzer MP, Solomon KD, Vroman DT, et al. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:2954-2958.
20. Fossardlo M, Peiretti E, Zueca I, Serra A. Photodynamic therapy of corneal neovascularization with verteporfin. Cornea. 2003;22:485-488.
21. Sawa M, Awazu K, Takahashi T, et al. Application of femtosecond ultrashort pulse laser to photodynamic therapy mediated by indocyanine green. Br J Ophthalmol. 2004;88:826-831.
22. Matumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res. 1986;46:6387-6392.
23. Nishiyama N, Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther. 2006;112:630-648.
24. Bae Y, Nishiyama N, Fukushima S, Koyama H, Matsumura Y, Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjugate Chem. 2005;16:122-130.
25. Nishiyama N, Okazaki S, Cabral H, et al. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 2003;63:8977-8983.